Literature DB >> 16483839

Universal Collection Medium (UCM) is as suitable as the Standard Transport Medium (STM) for Hybrid Capture II (HC-2) assay.

Nabiha Saadi Abrahão Taha1, José Focchi, Julisa Chamorro Lascasas Ribalta, Adauto Castelo, Attila Lorincz, Gerson Botacini Dôres.   

Abstract

BACKGROUND: Collection of cervical-vaginal material in liquid media enables simultaneous evaluation of both oncologic cytology and molecular tests for the detection of Human papillomavirus (HPV), Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). Universal Collection Medium (UCM) has been developed to fulfill this objective.
OBJECTIVES: To compare Hybrid Capture II (HC-2) to diagnose HPV, NG and CT in specimens collected in UCM and in the current Digene Standard Transport Medium (STM). STUDY
DESIGN: The study was cross-sectional. Three collections of endocervical and ectocervical material were performed in each of 893 women referred for colposcopy in the following order: (1) to prepare a conventional Pap smear slide using the accompanying brush of the STM kit and with Ayre spatula; (2) for HC-2 test and liquid-based cytology using a 1 ml UCM vial as transport medium; material was collected with another similar brush; (3) for HC-2 test using a 1 ml STM vial as transport medium; material was collected with the same brush that we used in the procedure no. (1) (conventional Pap smear). HC-2 results from samples taken from STM and UCM media were compared by using simple linear regression analysis and Kappa statistic. RESULTS AND
CONCLUSIONS: HC-2 results from the two media were highly correlated: high-risk HPV (kappa=0.92; r(2)=0.92), low-risk HPV (kappa=0.85; r(2)=0.86) and NG/CT (kappa=0.96; r(2)=0.81). Despite being obtained from a second specimen, the UCM HC-2 results were equivalent to those obtained with the standard medium STM and the UCM medium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483839     DOI: 10.1016/j.jcv.2005.12.011

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  2 in total

1.  High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.

Authors:  D C Rijkaart; D A M Heideman; V M H Coupe; A A T P Brink; R H M Verheijen; H Skomedal; F Karlsen; E Morland; P J F Snijders; C J L M Meijer
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

2.  Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples.

Authors:  Catterina Ferreccio; Alejandro Corvalán; Paula Margozzini; Paola Viviani; Claudia González; Ximena Aguilera; Patti E Gravitt
Journal:  BMC Public Health       Date:  2008-02-28       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.